Image 1
Vardenafil Hydrochloride Tablet, Film Coated
Product Images NDC 0093-7652
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Vardenafil Hydrochloride (NDC 0093-7652). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 10
This is a medication called Vardenafil Hydrochloride, which comes in a 2.5 mg dose and is dispensed with an attached patient information leaflet. It is indicated for oral consumption, and one tablet should be taken, no more than once per day. The medication should be stored in a container with a child-resistant closure at a controlled room temperature, and should be kept out of the reach of children. The medicine is manufactured in Israel by Teva Pharmaceutical Ind. Ltd for Teva Pharmaceuticals USA, Inc. It has a National Drug Code (NDC) of 0093-7652-56 and a Global Trade Item Number (GTIN) of 0300937652564.*
Image 11
This is a medication information leaflet for a tablet containing vardenafil. The dosage instruction is to take one tablet as needed, once per day. There is a warning to keep the medication out of reach of children. The tablet was manufactured in Israel by Teva Pharmaceutical Industries Ltd and manufactured for Teva Pharmaceuticals USA, Inc. There is a GTIN code and lot number provided. The rest of the content is illegible.*
Image 12
This is a medication information leaflet for hydrochloride tablets containing vardenafil, equivalent to 10 mg vardenafil HO. The recommended dosage is one tablet per day, with complete prescribing information provided. The medication should be stored at 20° to 25°C and dispensed in a tight container, out of the reach of children. It is manufactured in Israel by Teva Pharmaceutical Ind. Ltd for Teva Pharmaceuticals USA, Inc. This is a barcode-free area of the packaging.*
Image 13
This text is a patient information leaflet for a medication called vardenafil hydrochloride, which comes in a package of 30 tablets. Each tablet contains 20mg of vardenafil and should be taken no more than once a day as needed. The complete prescribing information for dosage and administration is included in the package. The medication should be stored at a temperature between 20°C and 25°C and kept out of reach of children. The manufacturer is Teva Pharmaceutical Ind. Ltd. in Israel, and it was manufactured for Teva Pharmaceuticals USA, Inc. The text also includes some identifying numbers, such as NDC 0093-7655-56 and GTIN 0300937655565. There is a code in the text, 323K507830518, which is marked as non-varnish/coding area.*
Image 2
Image 3
Image 4
The text contains a table or chart showing mean change (in mmHg) over time. The table has only one value, which is 15, and is not clear which variable is being measured. Therefore, it is not possible to provide a specific description of what the data represents.*
Image 5
Image 6
This appears to be a chart or graph showing the mean change in blood pressure in millimeters of mercury (mmHg) for two groups: one that received a placebo during stage 1, and another that received a drug called Varder. The chart shows that both groups had a mean change of around 10 mmHg (the vertical axis), but the timing of the placebo vs Varder treatment is unclear. Without more context, it is difficult to say what the significance of this chart is or what study it may come from.*
Image 7
Image 8
Image 9
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
